Printer Friendly

INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ANNOUNCES LAYOFFS AT MUREX DIAGNOSTICS LIMITED

 NORCROSS, Ga., Feb. 5 /PRNewswire/ -- International Murex Technologies Corporation (AMEX: MXX; TSE) (IMTC) announced today that its subsidiary, Murex Diagnostics Limited (MDL), has declared an across- the-board redundancy of 70 employees in the United Kingdom.
 This represents approximately 15 percent of MDL's U.K. work force and approximately 9 percent of IMTC's work force worldwide.
 In addition, IMTC announced that the MDL research and development staff will relocate to the company's Dartford operating facility, which will house all U.K. employees by mid-year. The final phase of IMTC's new Management Information System (MIS) is installed and operational. This system effectively eliminates the company's reliance on The Wellcome Foundation for financial reporting.
 These initiatives are part of the reorganization and consolidation plan announced by IMTC on Oct. 1, 1992.
 IMTC is a medical diagnostic products company dedicated to the development, manufacture and global marketing of cost-effective diagnostic products for infectious disease and blood transfusion practices.
 -0- 2/5/93
 /CONTACT: C. Robert Cusick, president and chief executive officer, or Marcia M. Young, director of corporate communications, of International Murex, 404-662-0660, or 800-322-1332/
 (MXX)


CO: International Murex Technologies; Murex Diagnostics Limited ST: Georgia IN: MTC SU:

RA-BN -- AT008 -- 3524 02/05/93 12:34 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 5, 1993
Words:203
Previous Article:WORLDSPAN TO ACQUIRE PARS SERVICE PARTNERSHIP
Next Article:ACOG, USOC ANNOUNCE CHAMPION, HANES AS PREMIER OLYMPIC KNIT ACTIVEWEAR APPAREL LICENSEES
Topics:


Related Articles
INTERNATIONAL MUREX TECHNOLOGIES ANNOUNCES FDA NOTIFICATION OF MANUFACTURING SITE INSPECTION
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ANNOUNCES FOURTH QUARTER AND 1992 YEAR END FINANCIAL RESULTS TO BE RELEASED BY APRIL 15
INTERNATIONAL MUREX TECHNOLOGIES NAMES FORMER SYNTEX DIVISION DIRECTOR TO HEAD INTERNATIONAL COMMERCIAL OPERATIONS
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ANNOUNCES THE ATLANTA CHAMBER OF COMMERCE SELECTS CEO TO HEAD BIOTECH TASK FORCE
U.K. COURT TO HOLD HEARING ON PUBLIC INTEREST IN BLOOD SUPPLY SAFETY CASE
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ANNOUNCES NEW GENERAL MANAGER OF NORTH, SOUTH AND CENTRAL AMERICA
U.K. COURT RULES ON THE MUREX CHIRON PATENT DISPUTE
INTERNATIONAL MUREX'S SUBSIDIARY ENTERS VOLUNTARY LIQUIDATION
INTERNATIONAL MUREX FILES PATENT INFRINGEMENT SUIT AGAINST ABBOTT LABORATORIES; DAMAGES ESTIMATED IN EXCESS OF $100 MILLION
International Murex Signs Distribution Agreement With American Bio Medica For Rapid Drugs of Abuse Test

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters